{
    "2020-06-23": [
        [
            {
                "time": "2021-03-15",
                "original_text": "Sarepta Addressing Gene Therapy Issue With Two Acquisitions",
                "features": {
                    "keywords": [
                        "Sarepta",
                        "Gene Therapy",
                        "Acquisitions"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-03-16",
                "original_text": "The Promise and Perils of Owning Pfizer",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Promise",
                        "Perils"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-17",
                "original_text": "Merck's Pneumococcal Vaccine Meets Goal in Two Adult Studies",
                "features": {
                    "keywords": [
                        "Merck",
                        "Vaccine",
                        "Studies"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-03-18",
                "original_text": "Pfizer Begins Four Phase III Studies on Vaccine Candidates",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Phase III",
                        "Vaccine"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-03-19",
                "original_text": "Oncolytics BiotechÂ® Doses First Patient in Phase 2 BRACELET-1 Study Evaluating Pelareorep-Based Combination Therapies in Metastatic Breast Cancer",
                "features": {
                    "keywords": [
                        "Oncolytics Biotech",
                        "Phase 2",
                        "Pelareorep",
                        "Breast Cancer"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "oncology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-03-20",
                "original_text": "Sanofi eyes approval of COVID-19 vaccine by first half of 2021",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "COVID-19",
                        "approval"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "vaccines"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}